APARNA KATOCH SAPRA,LUCA RASTELLI,VIMAL D. MEHTA,VIMAL D MEHTA
申请号：
BR112018000917
公开号：
BR112018000917A2
申请日:
2016.07.18
申请国别(地区):
BR
年份:
2018
代理人:
摘要：
The present invention discloses a method of treating, preventing or ameliorating tumor growth by administering a therapeutic agent that selectively inhibits dipeptidyl peptidase including fibroblast activation protein and dipeptidyl peptidase 8/9 in combination with an immune checkpoint inhibitor. The method specifically discloses use of Talabostat in combination with an immune checkpoint inhibitor, its pharmaceutical composition and process of preparing such composition.
